Efficacy/safety of entrectinib in patients (pts) with ROS1 -positive (ROS1 +) advanced/metastatic NSCLC from the Blood First Assay Screening Trial (BFAST)
Peters, Solange, Gadgeel, Shirish M., Mok, Tony S. K., Nadal, Ernest, Kilickap, Saadettin, Perol, Maurice, Cadranel, Jacques, Sugawara, Shunichi, Chiu, Chao-Hua, Moskovitz, Mor, Yu, Chong-Jen, Tanaka, Tomohiro, Nersesian, Rhea, Shagan, Sarah M., Maclennan, Margaret, Mathisen, Michael, Bhagawati Prasad, Vijay N S, Archer, Venice Rosalie, Dziadziuszko, Rafal
Published in Journal of clinical oncology (10.06.2022)
Published in Journal of clinical oncology (10.06.2022)
Get full text
Journal Article